Circulating dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis

Journal of Rheumatology

Volumn 38, Issue 5, 2011, Pages 821-827

  Wang, Shi Yao ^a   Liu, Yan Ying ^a   Ye, Hua ^a   Guo, Jian Ping ^a   Li, R U ^a   Liu, Xia ^a   Li, Zhan Guo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Dickkopf 1; Interleukin 1 receptor antagonist; Osteoprotegerin; Rheumatoid arthritis; Tumor necrosis factor inhibitor

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DICKKOPF 1 PROTEIN; INFLIXIMAB; OSTEOPROTEGERIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RHEUMATOID FACTOR;

ADULT; ANKYLOSING SPONDYLITIS; ANTIBODY TITER; ARTICLE; BONE EROSION; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BONE RESORPTION; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79955567265     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100089     Document Type: Article

References (26)

1. Sweeney SE, Firestein GS. Rheumatoid arthritis: Regulation of synovial inflammation. Int J Biochem Cell Biol 2004;36:372-8. (Pubitemid 37542434)
2. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61. (Pubitemid 40852711)
3. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, et al. The role of the wnt-signaling antagonist dkk1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003;349:2483-94. (Pubitemid 38010074)
4. Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, et al. Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005;8:751-64. (Pubitemid 40585297)
5. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, et al. Ldl-receptor-related protein 6 is a receptor for dickkopf proteins. Nature 2001;411:321-5. (Pubitemid 32467039)
6. Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by wnt signaling. J Clin Invest 2006;116:1202-9.
7. Goldring SR, Goldring MB. Eating bone or adding it: The wnt pathway decides. Nat Med 2007;13:133-4.
8. Gravallese EM, Goldring SR. Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum 2000;43:2143-51.
9. Fujita K, Janz S. Attenuation of wnt signaling by dkk-1 and -2 regulates bmp2-induced osteoblast differentiation and expression of opg, rankl and m-csf. Mol Cancer 2007;6:71.
10. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, et al. Human cardiovascular progenitor cells develop from a kdr+ embryonic stem cell derived population. Nature 2008;453:524-8. (Pubitemid 351733312)
11. Korb A, Tohidast-Akrad M, Cetin E, Axmann R, Smolen J, Schett G. Differential tissue expression and activation of p38 mapk alpha, beta, gamma, and delta isoforms in rheumatoid arthritis. Arthritis Rheum 2006;54:2745-56. (Pubitemid 44497753)
12. Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, et al. Evidence that dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 2010;62:150-8.
13. Karmakar S, Kay J, Gravallese EM. Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention. Rheum Dis Clin North Am 2010;36:385-404.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 1998;391:357-62. (Pubitemid 28093502)
16. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of wnt signaling inhibition mediated by dickkopf-1 interaction with lrp6/arrow. Nat Cell Biol 2001;3:683-6. (Pubitemid 32624426)
17. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, et al. Functional and structural diversity of the human dickkopf gene family. Gene 1999;238:301-13. (Pubitemid 29447031)
18. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007;13:156-63.
19. Lane NE, Nevitt MC, Lui LY, de Leon P, Corr M; Study of Osteoporotic Fractures Research Group. Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum 2007;56:3319-25.
20. Liu YY, Long L, Wang SY, Guo JP, Ye H, Cui LF, et al. Circulating Dickkopf-1 and osteoprotegerin in patients with early and longstanding rheumatoid arthritis. Chin Med J 2010;123:1407-12.
21. Lipsky PE, van der Heijde DM, St. Clair EW, Furst DE, Breedveld FC, Kalden JR, et al; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
22. Moreland L. Adalimumab in rheumatoid arthritis. Curr Rheumatol Rep 2004;6:333-4.
23. St. Clair EW. Infliximab treatment for rheumatic disease: clinical and radiological efficacy. Ann Rheum Dis 2002;61 Suppl 2: ii67-ii69.
24. Alessandri C, Bombardieri M, Papa N, Cinquini M, Magrini L, Tincani A, et al. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNF alpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann Rheum Dis 2004;63:1218-21. (Pubitemid 39273496)
25. Atzeni F, Sarzi-Puttini P, Dell'cqua D, de Portu S, Cecchini G, Cruini C, et al. Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study. Arthritis Res Ther 2006;8:R3.
26. Garnero P, Tabassi NC, Voorzanger-Rousselot N. Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanercept. J Rheumatol 2008;35:2313-5.